Legionella maceachernii pneumonia: a case report and literature review

Gaofeng Pan1,2,3, Maoying Fu1, Huihui Ni1

  • 1Department of Infectious Diseases, The First People's Hospital of Kunshan, Kunshan, Jiangsu, China.

Postgraduate Medicine
|July 31, 2024
PubMed
Abstract

Insights

Legionella maceachernii pneumonia, a severe infection, was successfully treated in an elderly patient in China. Rapid Dano-seq diagnosis and quinolone antibiotics proved effective for this rare condition.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Respiratory Medicine

Background:

  • Legionella maceachernii pneumonia is a rare but severe respiratory infection with high mortality.
  • Optimal treatment strategies for Legionella maceachernii pneumonia are not well-established.
  • This case represents the first reported successful treatment of Legionella maceachernii pneumonia in China.

Observation:

  • An 87-year-old male patient with multiple comorbidities was diagnosed with Legionella maceachernii pneumonia.
  • Diagnosis was confirmed using Dano-seq pathogen metagenomic testing.
  • The patient received a combination of cefoperazone/sulbactam and quinolone antibiotics.

Findings:

  • Dano-seq pathogen metagenomic testing offers rapid and accurate diagnosis of Legionella maceachernii pneumonia.
  • Combination therapy with cefoperazone/sulbactam and quinolone antibiotics led to successful patient recovery.
  • Oral quinolone antibiotics were effective for post-discharge treatment.

Implications:

  • This case highlights the utility of Dano-seq in diagnosing rare bacterial pneumonias.
  • Quinolone antibiotics are confirmed as an effective treatment option for Legionella maceachernii pneumonia.
  • Early diagnosis and appropriate antibiotic therapy are crucial for improving outcomes in severe Legionella infections.